The Global Resource For Connecting Buyers and Sellers

Swedish Cell Therapy Candidate CellProtect has Received Orphan Drug Designation for the Treatment of Multiple Myeloma

STOCKHOLM, Dec. 15, 2017 /PRNewswire/ —
CellProtect Nordic Pharmaceuticals AB (‘CPNP’) has been notified by the European Commission that its cell therapy candidate CellProtect has received orphan drug designation for the treatment of multiple myeloma. CellProtect is manufactured from…